Express News | JMP Securities Reiterates Market Outperform on Esperion Therapeutics, Maintains $7 Price Target

BenzingaJan 23 09:44 ET

A Quick Look at Today's Ratings for Esperion Therapeutics(ESPR.US), With a Forecast Between $2.05 to $16

Moomoo NewsJan 23 08:00 ET · Ratings

Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 A.m. ET.

GlobeNewswireJan 9 08:00 ET

BofA Securities Maintains Esperion Therapeutics(ESPR.US) With Sell Rating, Maintains Target Price $2.05

Moomoo NewsJan 6 06:34 ET · Ratings

Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 2 08:00 ET

Esperion Therapeutics Completes Financing Deals to Partially Repay Convertible Debt

MT NewswiresDec 18, 2024 08:34 ET